Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Return on Invested Capital (2023 - 2025)

Historic Return on Invested Capital for Agios Pharmaceuticals (AGIO) over the last 6 years, with Q4 2025 value amounting to 0.42%.

  • Agios Pharmaceuticals' Return on Invested Capital fell 1700.0% to 0.42% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.42%, marking a year-over-year decrease of 1700.0%. This contributed to the annual value of 0.34% for FY2025, which is 0.0% changed from last year.
  • Agios Pharmaceuticals' Return on Invested Capital amounted to 0.42% in Q4 2025, which was down 1700.0% from 0.4% recorded in Q3 2025.
  • Over the past 5 years, Agios Pharmaceuticals' Return on Invested Capital peaked at 0.25% during Q4 2024, and registered a low of 0.46% during Q4 2023.
  • Over the past 3 years, Agios Pharmaceuticals' median Return on Invested Capital value was 0.41% (recorded in 2023), while the average stood at 0.38%.
  • As far as peak fluctuations go, Agios Pharmaceuticals' Return on Invested Capital skyrocketed by 2100bps in 2024, and later tumbled by -1700bps in 2025.
  • Agios Pharmaceuticals' Return on Invested Capital (Quarter) stood at 0.46% in 2023, then surged by 45bps to 0.25% in 2024, then crashed by -67bps to 0.42% in 2025.
  • Its Return on Invested Capital was 0.42% in Q4 2025, compared to 0.4% in Q3 2025 and 0.25% in Q4 2024.